S&P 500   4,265.56 (-0.19%)
DOW   33,518.89 (-0.13%)
QQQ   353.30 (-0.45%)
AAPL   177.99 (-0.89%)
MSFT   334.13 (-0.54%)
META   270.67 (-0.27%)
GOOGL   125.98 (-0.02%)
AMZN   125.47 (+0.14%)
TSLA   214.23 (-1.55%)
NVDA   387.32 (-1.12%)
NIO   7.62 (-0.65%)
BABA   83.77 (-0.75%)
AMD   118.45 (+0.44%)
T   15.40 (+0.06%)
F   12.55 (-0.32%)
MU   66.94 (-1.22%)
CGC   0.75 (-3.95%)
GE   104.44 (+0.33%)
DIS   91.20 (+0.22%)
AMC   4.55 (-1.73%)
PFE   38.62 (-0.08%)
PYPL   64.29 (-0.34%)
NFLX   399.73 (-0.94%)
S&P 500   4,265.56 (-0.19%)
DOW   33,518.89 (-0.13%)
QQQ   353.30 (-0.45%)
AAPL   177.99 (-0.89%)
MSFT   334.13 (-0.54%)
META   270.67 (-0.27%)
GOOGL   125.98 (-0.02%)
AMZN   125.47 (+0.14%)
TSLA   214.23 (-1.55%)
NVDA   387.32 (-1.12%)
NIO   7.62 (-0.65%)
BABA   83.77 (-0.75%)
AMD   118.45 (+0.44%)
T   15.40 (+0.06%)
F   12.55 (-0.32%)
MU   66.94 (-1.22%)
CGC   0.75 (-3.95%)
GE   104.44 (+0.33%)
DIS   91.20 (+0.22%)
AMC   4.55 (-1.73%)
PFE   38.62 (-0.08%)
PYPL   64.29 (-0.34%)
NFLX   399.73 (-0.94%)
S&P 500   4,265.56 (-0.19%)
DOW   33,518.89 (-0.13%)
QQQ   353.30 (-0.45%)
AAPL   177.99 (-0.89%)
MSFT   334.13 (-0.54%)
META   270.67 (-0.27%)
GOOGL   125.98 (-0.02%)
AMZN   125.47 (+0.14%)
TSLA   214.23 (-1.55%)
NVDA   387.32 (-1.12%)
NIO   7.62 (-0.65%)
BABA   83.77 (-0.75%)
AMD   118.45 (+0.44%)
T   15.40 (+0.06%)
F   12.55 (-0.32%)
MU   66.94 (-1.22%)
CGC   0.75 (-3.95%)
GE   104.44 (+0.33%)
DIS   91.20 (+0.22%)
AMC   4.55 (-1.73%)
PFE   38.62 (-0.08%)
PYPL   64.29 (-0.34%)
NFLX   399.73 (-0.94%)
S&P 500   4,265.56 (-0.19%)
DOW   33,518.89 (-0.13%)
QQQ   353.30 (-0.45%)
AAPL   177.99 (-0.89%)
MSFT   334.13 (-0.54%)
META   270.67 (-0.27%)
GOOGL   125.98 (-0.02%)
AMZN   125.47 (+0.14%)
TSLA   214.23 (-1.55%)
NVDA   387.32 (-1.12%)
NIO   7.62 (-0.65%)
BABA   83.77 (-0.75%)
AMD   118.45 (+0.44%)
T   15.40 (+0.06%)
F   12.55 (-0.32%)
MU   66.94 (-1.22%)
CGC   0.75 (-3.95%)
GE   104.44 (+0.33%)
DIS   91.20 (+0.22%)
AMC   4.55 (-1.73%)
PFE   38.62 (-0.08%)
PYPL   64.29 (-0.34%)
NFLX   399.73 (-0.94%)
NYSE:AGL

agilon health (AGL) Competitors

$20.70
+0.48 (+2.37%)
(As of 06/5/2023 ET)
Compare
Today's Range
$20.15
$21.10
50-Day Range
$19.27
$28.46
52-Week Range
$15.00
$29.44
Volume
2.53 million shs
Average Volume
5.00 million shs
Market Capitalization
$8.59 billion
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$31.13

AGL vs. DVA, FMS, SHC, PGNY, INSP, KRTX, MASI, JAZZ, NBIX, and TEVA

Should you be buying agilon health stock or one of its competitors? The main competitors of agilon health include DaVita (DVA), Fresenius Medical Care AG & Co. KGaA (FMS), Sotera Health (SHC), Progyny (PGNY), Inspire Medical Systems (INSP), Karuna Therapeutics (KRTX), Masimo (MASI), Jazz Pharmaceuticals (JAZZ), Neurocrine Biosciences (NBIX), and Teva Pharmaceutical Industries (TEVA). These companies are all part of the "medical" sector.

agilon health vs.

DaVita (NYSE:DVA) and agilon health (NYSE:AGL) are both mid-cap medical companies, but which is the better investment? We will compare the two companies based on the strength of their valuation, profitability, institutional ownership, risk, earnings, community ranking, dividends, media sentiment and analyst recommendations.

DaVita has a beta of 0.93, suggesting that its stock price is 7% less volatile than the S&P 500. Comparatively, agilon health has a beta of 1.12, suggesting that its stock price is 12% more volatile than the S&P 500.

In the previous week, DaVita had 10 more articles in the media than agilon health. MarketBeat recorded 16 mentions for DaVita and 6 mentions for agilon health. DaVita's average media sentiment score of 0.87 beat agilon health's score of 0.48 indicating that DaVita is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
DaVita
4 Very Positive mention(s)
5 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
agilon health
1 Very Positive mention(s)
2 Positive mention(s)
3 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

DaVita has higher revenue and earnings than agilon health. agilon health is trading at a lower price-to-earnings ratio than DaVita, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
DaVita$11.61 billion0.77$560.40 million$5.4218.30
agilon health$3.19 billion2.69-$106.55 million-$0.22-94.09

DaVita presently has a consensus target price of $96.88, indicating a potential downside of 2.30%. agilon health has a consensus target price of $31.13, indicating a potential upside of 50.36%. Given agilon health's stronger consensus rating and higher possible upside, analysts clearly believe agilon health is more favorable than DaVita.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
DaVita
1 Sell rating(s)
5 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
2.00
agilon health
0 Sell rating(s)
1 Hold rating(s)
7 Buy rating(s)
0 Strong Buy rating(s)
2.88

DaVita has a net margin of 4.40% compared to agilon health's net margin of -2.88%. DaVita's return on equity of 72.08% beat agilon health's return on equity.

Company Net Margins Return on Equity Return on Assets
DaVita 4.40% 72.08% 3.59%
agilon health -2.88% -7.98% -4.54%

DaVita received 443 more outperform votes than agilon health when rated by MarketBeat users. Likewise, 61.83% of users gave DaVita an outperform vote while only 60.32% of users gave agilon health an outperform vote.

CompanyUnderperformOutperform
DaVitaOutperform Votes
481
61.83%
Underperform Votes
297
38.17%
agilon healthOutperform Votes
38
60.32%
Underperform Votes
25
39.68%

86.5% of DaVita shares are held by institutional investors. 1.4% of DaVita shares are held by insiders. Comparatively, 3.6% of agilon health shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.

Summary

DaVita beats agilon health on 12 of the 18 factors compared between the two stocks.


New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding AGL and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

AGL vs. The Competition

Metricagilon healthhealth & allied services, not elsewhere classified IndustryMedical SectorNYSE Exchange
Market Cap$8.59B$2.31B$4.53B$14.68B
Dividend YieldN/A1.90%6.07%3.99%
P/E Ratio-94.0924.67136.8021.12
Price / Sales2.6913.693,481.198.90
Price / CashN/A23.2022.2715.62
Price / Book8.184.334.656.97
Net Income-$106.55M$51.83M$116.46M$895.87M
7 Day Performance2.25%2.90%2.79%2.17%
1 Month Performance-15.54%2.60%1.07%1.22%
1 Year Performance5.88%-17.87%14.42%-8.62%

agilon health Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
DVA
DaVita
2.4051 of 5 stars
$92.42
-2.0%
$96.88
+4.8%
+2.5%$8.38B$11.61B17.0570,000
FMS
Fresenius Medical Care AG & Co. KGaA
3.0206 of 5 stars
$21.48
-0.5%
$28.45
+32.4%
-23.6%$12.61B$20.44B20.261,235Positive News
SHC
Sotera Health
1.7614 of 5 stars
$14.04
-2.0%
$16.50
+17.5%
-31.8%$3.97B$1.00B-15.103,000Positive News
PGNY
Progyny
2.5464 of 5 stars
$37.23
-0.4%
$48.86
+31.2%
+30.0%$3.51B$873.09M86.58311Insider Selling
Positive News
INSP
Inspire Medical Systems
2.1564 of 5 stars
$293.56
-0.2%
$312.56
+6.5%
+73.8%$8.51B$407.86M-188.18485Positive News
KRTX
Karuna Therapeutics
1.6358 of 5 stars
$221.01
+0.4%
$277.13
+25.4%
+118.7%$8.24B$11.29M-23.09118Analyst Report
MASI
Masimo
2.5918 of 5 stars
$156.13
-0.8%
$188.88
+21.0%
+17.7%$8.24B$2.04B71.626,000
JAZZ
Jazz Pharmaceuticals
2.5906 of 5 stars
$126.84
+0.7%
$200.75
+58.3%
-14.5%$8.12B$3.66B-49.942,800Insider Selling
NBIX
Neurocrine Biosciences
2.6766 of 5 stars
$90.11
-1.2%
$125.21
+39.0%
-1.8%$8.79B$1.49B150.191,200Analyst Report
TEVA
Teva Pharmaceutical Industries
2.0858 of 5 stars
$7.21
-3.4%
$10.67
+48.0%
-22.4%$8.00B$14.93B-5.0036,826

Related Companies and Tools

This page (NYSE:AGL) was last updated on 6/6/2023 by MarketBeat.com Staff

My Account -